The history of the Center for Molecular Imaging and Nuclear Medicine

The Clinique Générale-Beaulieu and the Clinique des Grangettes then joined forces in 2013 in the field of molecular imaging and nuclear medicine and created a common entity. The Geneva - IMGE Molecular Imaging Center, based on the sites of the two Clinics, aimed to optimize patient care, to share and expand the respective skills of the two existing centers.

The Clinique Générale-Beaulieu and the Clinique des Grangettes are unanimously recognized in medicine, surgery, as well as in all diagnostic techniques, medical imaging, specifically through their nuclear medicine center. Also called molecular medicine, it covers state-of-the-art techniques in hybrid molecular imaging PET/CT and SPECT/CT. These techniques are offered in the fields of oncology, radiotherapy, cardiology and musculoskeletal system.

Given the growing needs of each institution, particularly in the field of oncology, the general management of Hirslanden Clinique des Grangettes and Clinique Générale-Beaulieu have decided to end the activity of GRGB Santé SA on 31 December 2022 and to create two separate centers, one within each clinic.

From 1 January 2023, each clinic will open its own nuclear medicine centre.